@FierceMedDev: St. Jude stands firm despite more Durata scrutiny. More | Follow @FierceMedDev
@DamianFierce: In case you missed it, Intuitive Surgical shareholders are suing, claiming $ISRG withheld da Vinci problems. Article | Follow @DamianFierce
@MarkHFierce: Slow going for J&J's absorption of its massive Synthes acquisition, via Finance und Wirtschaft (translation req.). Story | Follow @MarkHFierce
@MichaelGFierce: Med tech lender MidCap readies for potential buyout. More | Follow @MichaelGFierce
> Cardiovascular Systems ($CSII) says data from its CONFIRM study series shows the company's orbital atherectomy system to treat peripheral artery disease had few problems in patients with and without renal disease. Item
> An implantable miniature telescope developed by VisionCare Ophthalmic Technologies to treat macular degeneration has shown promise as a corrective device in its first four patients. Story
> Gynecological diagnostic and surgical procedures will increasingly be performed in doctor's offices and at ambulatory surgical centers as the market becomes increasingly competitive, Millennium Research Group concludes in a new report. Item
> Cornell University engineers say that a smartphone-based system could help diagnose AIDS-related Kaposi's sarcoma through the use of gold nanoparticles combined with DNA snippets. Item
> Israel is launching an incubator fund intended, in part, to help draw further multinational investment in the country's already growing medical devices industry. Story
> In vitro diagnostics are growing at double the rate of the global pharmaceutical industry in some segments, Frost & Sullivan concludes in a new report. Item
Biotech News
@FierceBiotech: From FierceBiotechIT.com: Pharma giant Boehringer Ingelheim backs startup program Rock Health. Article | Follow @FierceBiotech
@JohnCFierce: Celgene's Revlimid OK'd for mantle cell lymphoma. Release | Follow @JohnCFierce
@RyanMFierce: Endo announces about 700 job cuts fresh from FDA denial of testosterone drug, facing generics competition. Release | Follow @RyanMFierce
@EmilyMFierce: One in 6 NIH research grant proposals get funding. That will be exacerbated by sequestration. Story | Follow @EmilyMFierce
> Biotech vet Westphal to exit CEO post of cancer drug developer Verastem. News
> Endo to slash 700 jobs after FDA setbacks. Article
> Pfizer turns to upstart CytomX for $635M deal on armed antibody tech. News
Pharma News
@FiercePharma: Sky-high drug prices will force change in cancer care, experts say, may save costs elsewhere. Yesterday's story | Follow @FiercePharma
@EricPFierce: Neptune starts work on its new omega 3 plant in Canada where last year's fatal explosion leveled operations. Article | Follow @EricPFierce
@CarlyHFierce: Avandia Adcomm hearings recap, Day 1: Article | Follow @CarlyHFierce
> Endo to cut 700 jobs, review asset sales in major restructuring. Article
> FDA official, panelists challenge Avandia safety trial. More
Pharma Manufacturing News
> Boehringer China biologics plant to do contract work. Story
> Impax cuts 110 jobs tied to problems at plant. Report
> Sanofi ramps up insulin production at Russian plant. News
> FDA issues warning letter for Novartis Ebewe plant. Article
Vaccines News
> FDA lifts clinical hold on anthrax vaccine. Item
> HPV vax awareness uneven despite Merck ad blitz. Report
> Novavax makes $30M bid for adjuvant business. Story
> U.S. pathogen team to locate in China CDC. More
> More New Yorkers skipping vaccines on religious grounds. Article